With this review we examined the activity of cefepime/zidebactam (WCK 5222) towards consecutive reference laboratory submissions of Gram-damaging microorganisms, taken like a sample of problem strains circulating in britain. The steadiness of cefepime towards AmpC, when combined with an ESBL-active BLI, supplies the protection of AmpC and ESBL coproducers, which https://lisah555ufp7.lotrlegendswiki.com/user